학술논문
PCN117 - Cost-Effectiveness of Crizotinib for Second and Third-Line Treatment of Non-Small Cell Lung Cancer in Ecuador
Document Type
Abstract
Author
Source
In Value in Health May 2018 21 Supplement 1:S30-S31
Subject
Language
ISSN
1098-3015